Randomised trial of text messaging on adherence to cardiovascular preventive treatment (INTERACT trial)

David S Wald1, Jonathan P Bestwick1, Lewis Raiman1

  • 1Wolfson Institute of Preventive Medicine, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, United Kingdom.

Plos One
|December 6, 2014
PubMed

Insights

Text messages significantly improved medication adherence for patients taking cardiovascular disease preventive treatments. This simple intervention helped more patients stay on their prescribed blood pressure and lipid-lowering drugs.

Area of Science:

  • Cardiology
  • Digital Health
  • Public Health

Background:

  • Medication non-adherence affects one-third of patients prescribed cardiovascular preventive drugs.
  • Poor adherence to blood pressure and lipid-lowering medications increases risks for coronary heart disease and stroke.

Purpose of the Study:

  • To evaluate the effectiveness of text messaging in improving medication adherence for cardiovascular disease prevention.

Main Methods:

  • A randomized trial involving 303 patients prescribed blood pressure and/or lipid-lowering medications.
  • Patients were assigned to receive daily, alternate-day, and then weekly text messages for 6 months or a control group.
  • Medication adherence and reasons for non-adherence were assessed via patient responses to automated texts.

Main Results:

  • Medication adherence improved in the text message group (9% non-adherence) compared to the control group (25% non-adherence).
  • Text messages reminded 65% of patients to take their medication, leading 13% to resume treatment after concerns.

Conclusions:

  • Text messaging is an effective strategy to enhance medication adherence in patients on cardiovascular preventive treatment.
  • This digital health intervention offers a scalable solution to improve cardiovascular disease prevention outcomes.
Abstract

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
880
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
11.2K
Randomized Experiments01:13

Randomized Experiments

The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
9.4K
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
946
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.5K
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
630